Science Explorer Back to mapMap
Discussion
Institution · AMAG Pharmaceuticals (United States)

Most cited papers from AMAG Pharmaceuticals (United States)

AMAG Pharmaceuticals (United States)

What are the most cited papers from AMAG Pharmaceuticals (United States)?

The most cited paper from AMAG Pharmaceuticals (United States) is "Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder" (Sheryl A. Kingsberg, Anita H. Clayton, David Jay Portman et al., 2019), with 296 citations. Next come "Ferumoxytol for Treating Iron Deficiency Anemia in CKD" (260) and "17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial" (236).

Showing 50 of 60 papers. Every paper with more than 10 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder Sheryl A. Kingsberg, Anita H. Clayton, David Jay Portman et al. · Obstetrics and Gynecology Open access 10 Oct 2019 296
2 Ferumoxytol for Treating Iron Deficiency Anemia in CKD Bruce Spinowitz, Annamaria T. Kausz, Jovanna Baptista et al. · Journal of the American Society of Nephrology Open access 4 Jun 2008 260
3 17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial Sean C. Blackwell et al. · American Journal of Perinatology Open access 25 Oct 2019 236
4 Female Sexual Health: Barriers to Optimal Outcomes and a Roadmap for Improved Patient–Clinician Communications Sheryl A. Kingsberg, Jonathan Schaffir, Brooke M. Faught et al. · Journal of Women s Health Open access 4 Feb 2019 224
5 Microneedle-based device for the one-step painless collection of capillary blood samples Timothy M. Blicharz, Ping Gong, Bernard M Bunner et al. · Nature Biomedical Engineering 16 Feb 2018 224
6 Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder James A. Simon, Sheryl A. Kingsberg, David Jay Portman et al. · Obstetrics and Gynecology Open access 10 Oct 2019 198
7 Randomized trial of intravenous iron-induced hypophosphatemia Myles Selig Wolf, Glenn Matthew Chertow, Iain C. Macdougall et al. · JCI Insight Open access 5 Dec 2018 196
8 Physicochemical properties of ferumoxytol, a new intravenous iron preparation V.S. Balakrishnan, Madhumathi Rao, Annamaria T. Kausz et al. · European Journal of Clinical Investigation 23 Apr 2009 145
9 Safety of Ferumoxytol in Patients With Anemia and CKD Ajay Singh, Tejas V. Patel, Joachim Hertel et al. · American Journal of Kidney Diseases 29 Sep 2008 145
10 Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial N. Franklin Adkinson, William Strauss, Iain C. Macdougall et al. · American Journal of Hematology Open access 8 Feb 2018 129
11 Encoded Library Synthesis Using Chemical Ligation and the Discovery of sEH Inhibitors from a 334-Million Member Library Alexander Litovchick, Christoph E. Dumelin, Sevan Habeshian et al. · Scientific Reports Open access 10 Jun 2015 104
12 A Randomized Comparison of Ferumoxytol and Iron Sucrose for Treating Iron Deficiency Anemia in Patients with CKD Iain C. Macdougall, William Strauss, Justin McLaughlin et al. · Clinical Journal of the American Society of Nephrology Open access 23 Jan 2014 101
13 Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia Sarah Acaster, Rene Dickerhoof, Kendra P.A. DeBusk et al. · Health and Quality of Life Outcomes Open access 16 May 2015 98
14 Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action Amaury E. Fernández‐Montalván et al. · ACS Chemical Biology Open access 18 Oct 2017 90
15 Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review John A. Glaspy, Michelle Z. Lim-Watson, Michael Libre et al. · Therapeutics and Clinical Risk Management ReviewOpen access Apr 2020 86
16 Discovery of a Potent BTK Inhibitor with a Novel Binding Mode by Using Parallel Selections with a DNA‐Encoded Chemical Library John W. Cuozzo, Diana Gikunju, Sevan Habeshian et al. · ChemBioChem Open access 5 Jan 2017 80
17 A Phase III, randomized, open‐label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy David J. Hetzel, William Strauss, Kristine E. Bernard et al. · American Journal of Hematology Open access 18 Mar 2014 79
18 Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron Saroj Vadhan‐Raj, William Strauss, David C. Ford et al. · American Journal of Hematology Open access 26 Aug 2013 77
19 Evaluation of Dexamethasone Phosphate Delivered by Ocular Iontophoresis for Treating Noninfectious Anterior Uveitis Amy E. Cohen, Carol Assang, Michael A. Patane et al. · Ophthalmology 24 Nov 2011 77
20 Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min Michael Auerbach, William Strauss, Sarah A Auerbach et al. · American Journal of Hematology Open access 5 Jul 2013 76
21 Ciraparantag, an anticoagulant reversal drug: mechanism of action, pharmacokinetics, and reversal of anticoagulants Jack Ansell, Bryan Laulicht, Sasha Bakhru et al. · Blood 18 Nov 2020 68
22 Health-related quality of life in patients with iron deficiency anemia: impact of treatment with intravenous iron William Strauss, Michael Auerbach · Patient Related Outcome Measures Open access Aug 2018 64
23 Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors Jeffrey W. Johannes et al. · ACS Medicinal Chemistry Letters Open access 27 Dec 2016 61
24 Ophthalmic Drug Delivery Using Iontophoresis: Recent Clinical Applications Victor L. Perez, Barbara M. Wirostko, Michael S. Korenfeld et al. · Journal of Ocular Pharmacology and Therapeutics 22 Nov 2019 58
25 Trans-scleral iontophoretic delivery of low molecular weight therapeutics Sevgi Güngör, Maria Begoña Delgado-Charro, Begoña Ruiz‐Perez et al. · Journal of Controlled Release Open access 24 Jul 2010 57
26 Discovery of cofactor-specific, bactericidal Mycobacterium tuberculosis InhA inhibitors using DNA-encoded library technology Holly H. Soutter, Matthew Clark, John W. Cuozzo et al. · Proceedings of the National Academy of Sciences Open access 18 Nov 2016 55
27 Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome John A. Glaspy, Myles Selig Wolf, William Strauss · Advances in Therapy Open access 30 May 2021 52
28 Ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in healthy elderly subjects Jack Ansell, Sasha Bakhru, Bryan Laulicht et al. · European Heart Journal Open access 8 Sep 2021 50
29 Agonists and Antagonists of Protease-Activated Receptor 2 Discovered within a DNA-Encoded Chemical Library Using Mutational Stabilization of the Target Dean G. Brown et al. · SLAS DISCOVERY Open access 12 Jan 2018 48
30 KDOQI US Commentary on the KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in CKD Craig E. Gordon, Ethan M. Balk, Bryan N. Becker et al. · American Journal of Kidney Diseases Open access Nov 2008 47
31 Aptamer BAX 499 mediates inhibition of tissue factor pathway inhibitor via interaction with multiple domains of the protein Emily K. Waters, Ryan M. J. Genga, Heather A. Thomson et al. · Journal of Thrombosis and Haemostasis Open access 25 Mar 2013 45
32 Role of Prohepcidin, Inflammatory Markers and Iron Status in Resistance to rhEPO Therapy in Hemodialysis Patients Elisio M. Costa, Brian J.G. Pereira, Petronila Rocha‐Pereira et al. · American Journal of Nephrology 2008 39
33 Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs Matthew R. Golder et al. · Nature Biomedical Engineering Open access 13 Aug 2018 37
34 Plasma Pharmacokinetics of Two Consecutive Doses of Ferumoxytol in Healthy Subjects Amy Barton Pai, Jace C. Nielsen, Annamaria Kausz et al. · Clinical Pharmacology & Therapeutics 30 Jun 2010 34
35 Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy Jesse Gerb, William Strauss, Richard J. Derman et al. · Therapeutic Advances in Hematology Open access 2021 33
36 Novel Nucleic Acid Binding Small Molecules Discovered Using DNA-Encoded Chemistry Alexander Litovchick, Tian Xia, Michael I. Monteiro et al. · Molecules Open access 27 May 2019 33
37 Mode of injection and treatment adherence: results of a survey characterizing the perspectives of health care providers and US women 18–45 years old David L. Gandell, E. Jay Bienen, Jennifer Gudeman · Patient Preference and Adherence Open access Feb 2019 31
38 The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women James G. Pfaus, Amama Sadiq, Carl Spana et al. · CNS Spectrums 18 Jan 2021 29
39 Suppression of inflammation and structural damage in experimental arthritis through molecular targeted therapy with PPI‐2458 Gerhard Hannig, Sylvie G. Bernier, Jennifer G. Hoyt et al. · Arthritis & Rheumatism 27 Feb 2007 29
40 Ferumoxytol versus iron sucrose treatment: a post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemia William Strauss, Naomi V. Dahl, Zhu Li et al. · BMC Hematology Open access 26 Jul 2016 28
41 Differential responses in CBF and CBV to cocaine as measured by fMRI: Implications for pharmacological MRI signals derived oxygen metabolism assessment Feng Roger Luo, Karl F. Schmidt, Gerard B. Fox et al. · Journal of Psychiatric Research 9 Jan 2009 28
42 Evaluation of Ocular and General Safety Following Repeated Dosing of Dexamethasone Phosphate Delivered by Transscleral Iontophoresis in Rabbits Michael A. Patane, William Schubert, Thomas Richard Sanford et al. · Journal of Ocular Pharmacology and Therapeutics 11 Jul 2013 28
43 DISC1 regulates N-methyl-D-aspartate receptor dynamics: abnormalities induced by a Disc1 mutation modelling a translocation linked to major mental illness Elise L.V. Malavasi et al. · Translational Psychiatry Open access 6 Sep 2018 27
44 Ocular translational science: A review of development steps and paths Brenda K. Mann, Darren Lars Stirland, Hee‐Kyoung Lee et al. · Advanced Drug Delivery Reviews Review Feb 2018 26
45 Requirements for multi-level systems pharmacology models to reach end-usage: the case of type 2 diabetes Elin Nyman, Yvonne J.W. Wesseling-Rozendaal, Gabriel Helmlinger et al. · Interface Focus Open access 19 Feb 2016 25
46 Universal strategies for the DNA-encoding of libraries of small molecules using the chemical ligation of oligonucleotide tags Alexander Litovchick, Matthew Clark, Anthony D. Keefe · Artificial DNA PNA & XNA Open access 22 Jan 2014 25
47 Chemical ligation methods for the tagging of DNA-encoded chemical libraries Anthony D. Keefe, Matthew Clark, Christopher D. Hupp et al. · Current Opinion in Chemical Biology Review 7 Mar 2015 23
48 Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial Iain C. Macdougall, William Strauss, Naomi V. Dahl et al. · Clinical Nephrology Open access 25 Feb 2019 21
49 Application of a Substrate-Mediated Selection with c-Src Tyrosine Kinase to a DNA-Encoded Chemical Library Dongwook Kim, Yixing Sun, Dan Xie et al. · Molecules Open access 30 Jul 2019 19
50 The pharmacokinetics of the lymphotropic nanoparticle MRI contrast agent ferumoxtran-10 Tina Islam, Gerald L Wolf · Cancer Biomarkers Open access 2 Mar 2009 19

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.